CVE-2021-34782

Cisco DNA Center Information Disclosure Vulnerability

Description

A vulnerability in the API endpoints for Cisco DNA Center could allow an authenticated, remote attacker to gain access to sensitive information that should be restricted. The attacker must have valid device credentials. This vulnerability is due to improper access controls on API endpoints. An attacker could exploit the vulnerability by sending a specific API request to an affected application. A successful exploit could allow the attacker to obtain sensitive information about other users who are configured with higher privileges on the application.

Category

4.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.13%
Vendor Advisory cisco.com
Affected: Cisco Cisco Digital Network Architecture Center (DNA Center)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-34782?
CVE-2021-34782 has been scored as a medium severity vulnerability.
How to fix CVE-2021-34782?
To fix CVE-2021-34782, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-34782 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-34782 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-34782?
CVE-2021-34782 affects Cisco Cisco Digital Network Architecture Center (DNA Center).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.